Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194643 · ClinicalTrials.gov registry record
Platelets in Pregnancy
A clinical trial of Hypertensive Disorder of Pregnancy, sponsored by NYU Langone Health.
- Active
- Registry status
- 66
- Enrollment target
- 1
- Study location
NCT06194643 is a study of Hypertensive Disorder of Pregnancy that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 66 participants, below the 2,691-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06194643, a study of Hypertensive Disorder of Pregnancy, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06194643
The ClinicalTrials.gov registry entry for NCT06194643 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,691-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertensive Disorder of Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT06194643 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06194643 about?
NCT06194643 is a clinical study titled "Platelets in Pregnancy". This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in p...
What is the current status of trial NCT06194643?
This trial is currently active not recruiting. The enrollment target is 66 participants. The study started on 2023-01-17. Estimated completion is 2026-03.
What conditions does trial NCT06194643 study?
This clinical trial studies the following conditions: Hypertensive Disorder of Pregnancy.
Who is sponsoring clinical trial NCT06194643?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06194643 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertensive Disorder of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
The Preeclampsia Registry
RECRUITING
-
Microbial Metabolites and Outcomes of Pregnancy Study
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.